The online version of this article (doi:10.1186/s12985-017-0697-5) contains supplementary material, which is available to authorized users.
Vaccination of poultry to control highly pathogenic avian influenza virus (HPAIV) H5N1 is used in several countries. HPAIV H5N1 of clade 2.2.1 which is endemic in Egypt has diversified into two genetic clades. Clade 220.127.116.11 represents antigenic drift variants in vaccinated commercial poultry while clade 18.104.22.168 variants are detected in humans and backyard poultry. Little is known about H5N1 infection in vaccinated turkeys under field conditions.
Here, we describe an HPAI H5N1 outbreak in a vaccinated meat-turkey flock in Egypt. Birds were vaccinated with inactivated H5N2 and H5N1 vaccines at 8 and 34 days of age, respectively. At 72nd day of age (38 days post last vaccination), turkeys exhibited mild respiratory signs, cyanosis of snood and severe congestion of the internal organs. Survivors had a reduction in feed consumption and body gain. A mortality of ~29% cumulated within 10 days after the onset of clinical signs. Laboratory diagnosis using RT-qPCRs revealed presence of H5N1 but was negative for H7 and H9 subtypes. A substantial antigenic drift against different serum samples from clade 22.214.171.124 and clade 126.96.36.199 was observed. Based on full genome sequence analysis the virus belonged to clade 188.8.131.52 but clustered with recent H5N1 viruses from 2015 in poultry in Israel, Gaza and Egypt in a novel subclade designated here 184.108.40.206a which is distinct from 2014/2015 220.127.116.11 viruses. These viruses possess 18.104.22.168 clade-specific genetic signatures and also mutations in the HA similar to those in clade 22.214.171.124 that enabled evasion from humoral immune response. Taken together, this manuscript describes a recent HPAI H5N1 outbreak in vaccinated meat-turkeys in Egypt after infection with a virus representing novel distinct 126.96.36.199a subclade.
Infection with HPAIV H5N1 in commercial turkeys resulted in significant morbidity and mortality despite of vaccination using H5 vaccines. The isolated virus showed antigenic drift and clustered in a novel cluster designated here 188.8.131.52a related to viruses in poultry in Israel, Gaza and Egypt. Enforcement of biosecurity and constant update of vaccine virus strains may be helpful to protect vaccinated birds and prevent spillover infection to neighbouring countries.
Additional file 1: Table S1. Amino acids differences from A/turkey/Egypt/AR1507/2016 and ancestral 2006 virus, vaccine strain and closest human isolate (DOC 36 kb)12985_2017_697_MOESM1_ESM.doc
Additional file 2: Figure S1. Phylogenetic analysis of internal protein coding gene segments of A/turkey/Egypt/AR1507/2016 to other related H5N1 viruses in poultry and humans. Phylogenetic analysis of non HA/NA genes of Egyptian viruses showing different genetic clades. Viruses in 2015 from Egypt including A/turkey/Egypt/AR1507/2016 are clustered in clade 184.108.40.206. The tree was generated by MrBayes under the best-fit model selected by jModelTest. (PDF 701 kb)12985_2017_697_MOESM2_ESM.pdf
Yoon SW, Webby RJ, Webster RG. Evolution and ecology of influenza a viruses. Curr Top Microbiol Immunol. 2014;385:359–75. PubMed
Smith GJ, Donis RO. World health organization/world organisation for animal HF, agriculture organization HEWG: nomenclature updates resulting from the evolution of avian influenza a(H5) virus clades 220.127.116.11a, 2.2.1, and 2.3.4 during 2013–2014. Influenza Other Respir Viruses. 2015;9:271–6. CrossRefPubMedPubMedCentral
Cilloni F, Toffan A, Giannecchini S, Clausi V, Azzi A, Capua I, Terregino C. Increased pathogenicity and shedding in chickens of a wild bird-origin low pathogenicity avian influenza virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. Avian Dis. 2010;54:555–7. CrossRefPubMed
Long NT, Thanh TT, van Doorn HR, Vu PP, Dung PT, Dung TT, Tien TN, Thao DT, Hung P, Quang NV, et al. Recent avian influenza virus a/H5N1 evolution in vaccinated and unvaccinated poultry from farms in southern Vietnam, january-march 2010. Transbound Emerg Dis. 2011;58:537–43. CrossRefPubMedPubMedCentral
Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Mizuike R, Hiramatsu H, Sriwilaijaroen N, Takagi T, Suzuki Y, Ikuta K. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog. 2011;7:e1002068. CrossRefPubMedPubMedCentral
Grund C, el SM A, Arafa AS, Ziller M, Hassan MK, Aly MM, Hafez HM, Harder TC, Beer M. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine. 2011;29:5567–73. CrossRefPubMed
Kilany WH, Abdelwhab EM, Arafa AS, Selim A, Safwat M, Nawar AA, Erfan AM, Hassan MK, Aly MM, Hafez HM. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus. Vet Microbiol. 2011;150:28–34. CrossRefPubMed
Watanabe Y, Arai Y, Daidoji T, Kawashita N, Ibrahim MS, El-Gendy Eel D, Hiramatsu H, Kubota-Koketsu R, Takagi T, Murata T, et al. Characterization of H5N1 influenza virus variants with hemagglutinin mutations isolated from patients. MBio. 2015;6(2).
Cattoli G, Milani A, Temperton N, Zecchin B, Buratin A, Molesti E, Aly MM, Arafa A, Capua I. Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol. 2011;85:8718–24. CrossRefPubMedPubMedCentral
OIE. Chapter 2.3.4. — avian influenza. 2015. Available at: http://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/2.03.04_AI.pdf.
Hall T. BioEdit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Symp Ser. 1999;41:95–8.
- Isolation and genetic characterization of a novel 18.104.22.168a H5N1 virus from a vaccinated meat-turkeys flock in Egypt
Ahmed H. Salaheldin
Hatem S. Abd El-Hamid
Timm C. Harder
Thomas C. Mettenleiter
Hafez M. Hafez
Elsayed M. Abdelwhab
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II